(PharmaNewsWire.Com, May 09, 2017 ) A latest research report titled as ”United States Next Generation Cancer Diagnostics Market: Size, Growth Factors and Industry Forecast 2022” has been recently added to the vast portfolio of Market Research Hub (MRH) online research offerings. This report is a professional and in-depth analysis on the present state and future prospect for the global market. It provides valuable information to the industry insiders, potential entrants or investors. It includes an exhaustive enquiry with the reliability of logic and the comprehensiveness of contents.
This report studies sales (consumption) of Next Generation Cancer Diagnostics in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering Cepheid Koninklijke Philips N.V F. Hoffmann-La Roche Ltd Qiagen Novartis AG Abbott Thermo Fisher Scientific Opko Health Myriad Genetics Agilent Technologies GE Healthcare PerkinElmer Genomic Health Illumina Hologic Almac Group Janssen Global Services Sysmex Corporation
Market Segment by States, covering California Texas New York Florida Illinois Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into Next Generation Sequencing qPCR & Multiplexing Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR) Protein Microarrays DNA Microarrays Split by applications, this report focuses on sales, market share and growth rate of Next Generation Cancer Diagnostics in each application, can be divided into Lung Cancer Breast Cancer Colorectal Cancer Cervical Cancer Others
Table Of Content:
1 Next Generation Cancer Diagnostics Overview 1.1 Product Overview and Scope of Next Generation Cancer Diagnostics 1.2 Classification of Next Generation Cancer Diagnostics 1.2.1 Next Generation Sequencing 1.2.2 qPCR & Multiplexing
2 United States Next Generation Cancer Diagnostics Competition by Manufacturers 2.1 United States Next Generation Cancer Diagnostics Sales and Market Share of Key Manufacturers (2015 and 2016) 2.2 United States Next Generation Cancer Diagnostics Revenue and Share by Manufactures (2015 and 2016) 2.3 United States Next Generation Cancer Diagnostics Average Price by Manufactures (2015 and 2016)
In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of Pharmaceuticals and Healthcare Market Research Reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
Contact Us 90 State Street, Albany, NY 12207, United States Toll Free : 866-997-4948 (US-Canada) Tel : +1-518-621-2074 Email : firstname.lastname@example.org Website : http://www.marketresearchhub.com/
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: